Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioharvest Sciences Inc (CSE: BHSC )

0.2600 +0.0050 (+1.96%)
Official Closing Price Updated: 2:00 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,900
Open 0.2550
Bid (Size) 0.2400 (1,000)
Ask (Size) 0.2600 (8,000)
Prev. Close 0.2550
Today's Range 0.2500 - 0.2600
52wk Range 0.1400 - 0.3000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded... 
Via Newsfile
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile

Performance

YTD
+23.81%
+23.81%
1 Month
-7.14%
-7.14%
3 Month
+20.93%
+20.93%
6 Month
+62.50%
+62.50%
1 Year
+8.33%
+8.33%

More News

Read More
Benzinga's 2024 Virtual Healthcare: What's Next In Health?
Via Benzinga
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
Via Newsfile
RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024
Via ACCESSWIRE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
Via Newsfile
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
Via Newsfile
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
Via Newsfile
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Via Newsfile
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
Via Newsfile
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
Via Newsfile
Life Science Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
Via Newsfile
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
Via Newsfile
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
Via Newsfile
BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum
Via Newsfile
BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023
Via Newsfile
BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
Via Newsfile
BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference
Via Newsfile
BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto
Via Newsfile
BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27
Via Newsfile
BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.